Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Patients with a hematological malignancy who are undergoing intensive chemotherapy need a central venous catheter (CVC)during their treatment. CVCs are locked with heparin when they are not used. The purpose of this study is to determine whether concentrated citrate locking, compared to heparin, reduces the incidence of central venous catheter-related thrombosis and infections in patients with hematological malignancies undergoing intensive chemotherapy.
Epistemonikos ID: afa4a22ca5bdd5c1260877c9ea001fec2fe6bcc2
First added on: May 11, 2024